| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Normal
|
Disease state |
|
|
Moderate spinal cord injury
|
Disease state |
|
|
Peritoneal fat
|
Organism part |
|
|
Kidney
|
Organism part |
|
|
Neurointermediate lobe
|
Organism part |
|
|
Breast cancer
|
Disease state |
|
|
N-methyl-N-nitrosurea
|
Compound treatment |
|
|
Control
|
Compound treatment |
|
|
E16
|
Developmental stage |
|
|
Interleukin 1 beta and glucosa...
|
Compound treatment |
|
|
Glucosamine
|
Compound treatment |
|
|
Single exposure
|
Protocol type |
|
|
Repeated exposure
|
Protocol type |
|
|
Paraventricular nucleus
|
Organism part |
|
|
Supraoptic nucleus
|
Organism part |
|
|
Severe spinal cord injury
|
Disease state |
|
|
Interleukin 1 beta
|
Compound treatment |
|
|
Cerebellum
|
Organism part |
|
|
Hippocampus
|
Organism part |
|
|
Control diet
|
Growth condition |
|
|
Ketogenic diet
|
Growth condition |
|
|
E14
|
Developmental stage |
|
|
Spermatocytes
|
Target cell type |
|
|
Spermatogonia
|
Target cell type |
|
|
RI(SHR/OlaXBN-Lx/Cub)
|
Strain or line |
|
|
Raphe magnus
|
Organism part |
|
|
Somatomotor cortex
|
Organism part |
|
|
|
|
|
Processing time: 0.078 secs.